TY - JOUR
T1 - Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")
AU - Miyata, T.
AU - Sugiyama, S.
AU - Saito, A.
AU - Kurokawa, K.
PY - 2001
Y1 - 2001
N2 - Many studies on uremic toxins have focused on enzymatic biochemistry. Recently, attention has turned to nonenzymatic biochemistry, especially progressive and irreversible modifications of proteins. Two different approaches opened the field of irreversible nonenzymatic modifications of proteins in uremia: the advanced glycation end products (AGEs) derived from the Maillard reaction and the advanced lipoxidation end products (ALEs) derived from lipid peroxidation. They have revealed the accumulation of reactive carbonyl compounds (RCOs) derived from carbohydrates and lipids and the subsequent carbonyl modifications of proteins ("carbonyl stress"). In this article, we describe the causal role of various RCOs and AGEs/ ALEs accumulating in uremia, the clinical consequences of carbonyl stress in uremia, and finally, the therapeutic perspectives. We propose carbonyl stress as a new uremic toxicity.
AB - Many studies on uremic toxins have focused on enzymatic biochemistry. Recently, attention has turned to nonenzymatic biochemistry, especially progressive and irreversible modifications of proteins. Two different approaches opened the field of irreversible nonenzymatic modifications of proteins in uremia: the advanced glycation end products (AGEs) derived from the Maillard reaction and the advanced lipoxidation end products (ALEs) derived from lipid peroxidation. They have revealed the accumulation of reactive carbonyl compounds (RCOs) derived from carbohydrates and lipids and the subsequent carbonyl modifications of proteins ("carbonyl stress"). In this article, we describe the causal role of various RCOs and AGEs/ ALEs accumulating in uremia, the clinical consequences of carbonyl stress in uremia, and finally, the therapeutic perspectives. We propose carbonyl stress as a new uremic toxicity.
KW - Advanced glycation end products
KW - Advanced lipoxidation end products
KW - Carbohydrates
KW - Lipids
KW - Nonenzymatic biochemistry
KW - Renal failure
KW - Uremia
UR - http://www.scopus.com/inward/record.url?scp=0035130251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035130251&partnerID=8YFLogxK
U2 - 10.1046/j.1523-1755.2001.59780025.x
DO - 10.1046/j.1523-1755.2001.59780025.x
M3 - Article
C2 - 11168978
AN - SCOPUS:0035130251
SN - 0098-6577
VL - 59
SP - S25-S31
JO - Kidney International, Supplement
JF - Kidney International, Supplement
IS - 78
ER -